News

ASCO 2015: Dr. Johanna Bendell gives her top picks in gastrointestinal research


 

References

Dr. Johanna Bendell picks the upcoming ASCO presentations she anticipates to be the most interesting in gastrointestinal research.

Dr. Johanna Bendell

Dr. Johanna Bendell

3504 Impact of aspirin as secondary prevention in an unselected cohort of 25,644 patients with colorectal cancer: A population-based study.

3503 Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance).

Dr. Johanna Bendell is the director, GI Oncology Research, and associate director, drug development unit, Sarah Cannon Research Institute, Nashville, Tenn.

Recommended Reading

Ramucirumab approval expanded to include metastatic colorectal cancer indication
MDedge Hematology and Oncology
VIDEO: NAFLD increasingly causing U.S. hepatocellular carcinomas
MDedge Hematology and Oncology
HCV increases general cancer risk
MDedge Hematology and Oncology
Biomarker correlates with pancreatic cancer severity
MDedge Hematology and Oncology
ILC: NAFLD a stealth trigger of hepatocellular carcinoma
MDedge Hematology and Oncology
ASA: Electroporation shows promise for locally advanced pancreatic cancer
MDedge Hematology and Oncology
DDW: VIDEO: What we don’t know in the management of liver disease and coagulopathy
MDedge Hematology and Oncology
DDW: Scheduled for a colonoscopy? Pass the pretzels!
MDedge Hematology and Oncology
DDW: Urinary enzymes hint at gastric cancer
MDedge Hematology and Oncology
David Henry's JCSO podcast, April 2015
MDedge Hematology and Oncology